Jiangsu gdk Biotechnology Co., Ltd. (688670.SS)
CNY 14.38
(0.0%)
CNY 14.38
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 80.9 Million | 38.59 Million | 103.92 Million | 109.45 Million | -54.04 Million | -35.47 Million |
| Net Income | -70.99 Million | 41.54 Million | 82.46 Million | 154.97 Million | -19.03 Million | -28.01 Million |
| Depreciation & Amortization | 29.87 Million | 29.75 Million | 28.07 Million | 25.8 Million | 23.29 Million | 21.06 Million |
| Deferred income taxes | -15.58 Million | 3.77 Million | -14.64 Million | 49.95 Million | -12.2 Million | -13.35 Million |
| Stock-based compensation | - | 757.38 Thousand | 729.43 Thousand | 14.98 Million | - | - |
| Change in working capital | 87.19 Million | -61.25 Million | -70.31 Million | -112.26 Million | -57.63 Million | -14.22 Million |
| Other non-cash items | 34.82 Million | 24.01 Million | 77.62 Million | -24.01 Million | -672.4 Thousand | -14.3 Million |
| Investing Cash Flow | -187.7 Million | 112.69 Million | -996.39 Million | -71.25 Million | -24.41 Million | -611.41 Thousand |
| Investments in PPE | -54 Million | -168.17 Million | -386.38 Million | -40.8 Million | -21.12 Million | -6.21 Million |
| Acquisitions | 145 Million | - | 50 Thousand | 15 Thousand | - | - |
| Investment purchases | -145 Million | - | -615 Million | -15 Thousand | - | - |
| Sales/Maturities of investments | 11.29 Million | 15.87 Million | 4.94 Million | 404.8 Thousand | 85.9 Thousand | 68.3 Thousand |
| Other Investing Activities | -144.99 Million | 265 Million | 0.70 | -30.85 Million | -3.37 Million | 5.54 Million |
| Financing Cash Flow | 2.51 Million | -13.25 Million | 841.13 Million | 42.26 Million | 82.34 Million | 39.53 Million |
| Debt repayment | -44 Million | -20 Million | -515.95 Million | -134.5 Million | -53.5 Million | -45 Million |
| Dividends payments | -17.6 Million | -44 Million | -9.85 Million | -8.43 Million | -3.15 Million | -4.56 Million |
| Common Stock Repurchased | - | - | 13.12 Million | - | - | - |
| Common Stock Issuance | - | - | -13.12 Million | - | - | - |
| Other Financing Activities | 20.11 Million | 52 Million | 1.36 Billion | 185.2 Million | 139 Million | 89.09 Million |
| Accounts receivables | 241.6 Million | -7.18 Million | 13.37 Million | -307.64 Million | -62.51 Million | -179 Thousand |
| Accounts payables | -93.99 Million | -18.81 Million | -20.12 Million | 160.24 Million | 32.62 Million | 1.12 Million |
| Inventory | -44.83 Million | -39.03 Million | -48.91 Million | -14.82 Million | -15.53 Million | -1.82 Million |
| Other working capital | -15.58 Million | 3.77 Million | -14.64 Million | 49.95 Million | -12.2 Million | -12.4 Million |
| Cash at beginning of period | 174.72 Million | 36.68 Million | 88.01 Million | 7.55 Million | 3.67 Million | 229.89 Thousand |
| Cash at end of period | 70.44 Million | 174.72 Million | 36.68 Million | 88.01 Million | 7.55 Million | 3.67 Million |
| Capital Expenditure | -54 Million | -168.17 Million | -386.38 Million | -40.8 Million | -21.12 Million | -6.21 Million |
| Effect of forex changes on cash | 1.08 | 2334.42 | - | 1.22 | - | - |
| Net cash flow / Change in cash | -104.28 Million | 138.04 Million | -51.32 Million | 80.46 Million | 3.87 Million | 3.44 Million |
| Free Cash Flow | 26.9 Million | -129.58 Million | -282.46 Million | 68.64 Million | -75.17 Million | -41.69 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -12.59 Million | -19.37 Million | -21.49 Million | -54.7 Million | -70.99 Million | -46.15 Million |
| Depreciation & Amortization | - | 7.57 Million | 7.57 Million | 7.81 Million | 29.87 Million | -14.34 Million |
| Deferred income taxes | - | - | - | - | -15.58 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 8.95 Million | - | 196.77 Million | 87.19 Million | -66.65 Million |
| Other non-cash items | -23.65 Million | -12.07 Million | -21.7 Million | -127.18 Million | 34.82 Million | 130.65 Million |
| Investing Cash Flow | -74.58 Million | 110.92 Million | 53.55 Million | -371.76 Million | -187.7 Million | 120.08 Million |
| Investments in PPE | -4.93 Million | -6.78 Million | -11.65 Million | -35.82 Million | -54 Million | -2.75 Million |
| Acquisitions | - | 37 Thousand | 205.92 Thousand | 145 Million | 145 Million | - |
| Investment purchases | - | - | -2.15 Million | -145 Million | -145 Million | - |
| Sales/Maturities of investments | 1.81 Million | 182.67 Million | 2.15 Million | 4.06 Million | 11.29 Million | 2.83 Million |
| Other Investing Activities | -71.46 Million | -65 Million | 65 Million | -339.99 Million | -144.99 Million | 120 Million |
| Financing Cash Flow | 2.06 Million | -11.27 Million | 3.56 Million | -7.5 Million | 2.51 Million | 652.4 Thousand |
| Debt repayment | -2.4 Million | -10.8 Million | -4 Million | -7 Million | -44 Million | -18 Million |
| Dividends payments | -330.81 Thousand | -473.35 Thousand | -437.65 Thousand | -502.02 Thousand | -17.6 Million | -547.59 Thousand |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -473.35 Thousand | -437.65 Thousand | -8.88 Million | 20.11 Million | 19.19 Million |
| Accounts receivables | - | 37.7 Million | - | 241.6 Million | 241.6 Million | -116.57 Million |
| Accounts payables | - | - | - | - | -93.99 Million | - |
| Inventory | - | -28.75 Million | - | -44.83 Million | -44.83 Million | 49.92 Million |
| Other working capital | - | - | - | - | -15.58 Million | - |
| Cash at beginning of period | 144.98 Million | 84.36 Million | 70.44 Million | 430.56 Million | 174.72 Million | 308.61 Million |
| Cash at end of period | 34.4 Million | 160.78 Million | 84.36 Million | 70.44 Million | 70.44 Million | 430.56 Million |
| Capital Expenditure | -4.93 Million | -6.78 Million | -11.65 Million | -35.82 Million | -54 Million | -2.75 Million |
| Effect of forex changes on cash | - | - | 1.00 | -3.56 Million | 1.08 | -2.28 Million |
| Net cash flow / Change in cash | -110.58 Million | 76.42 Million | 13.92 Million | -360.12 Million | -104.28 Million | 121.95 Million |
| Free Cash Flow | -41.18 Million | -45.81 Million | -54.84 Million | -13.12 Million | 26.9 Million | 742.7 Thousand |
2001
4180
6712
VPHIF
VNUE
PTMP